Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: JOHN W. who wrote (2600)	11/3/1997 2:00:00 AM
From: billkirn	Read Replies (1) \| Respond to of 6136

John, I agree with your long term position. Only the short term is troublesome, and this might last only a month or two. It could be viewed as a great opportunity to buy this stock at low valuations. By the way, the new Tempelton Biotech Discovery fund has a sizable position in AGPH. Bill

To: JOHN W. who wrote (2600)	11/3/1997 1:19:00 PM
From: Peter Church	Read Replies (3) \| Respond to of 6136

No more short term price targets, please!!! I wholeheartedly agree with your last post and frankly was pissed off about your harping on $70 by November. You may just be playing with numbers and charts, but a lot of people who read this thread probably got sucked up into your veneer of "expertise" about the price and made investment decisions based on your target. The recent decline demonstrates that even great companies can have lots of volatility in their stock. And prices will take unexpected dives. So, I'm asking you to please restrain yourself and don't post price targets. It's too risky!!!